Does Magnesium Help Arthritis? Here's What the Research Says

Here is what the clinical evidence actually says, what it does not say, and how to apply it if you are living with arthritis.

Magnesium is involved in over 300 enzymatic reactions in the body, including several that directly overlap with what goes wrong in arthritic joints. It helps regulate inflammatory signalling, supports cartilage and bone metabolism, and influences how your immune system behaves. When magnesium levels are low, inflammatory markers like C-reactive protein (CRP) tend to be elevated, and that is relevant because chronic low-grade inflammation is a hallmark of both RA and OA.

A 2024 cross-sectional study of over 20,500 adults using NHANES data found a dose-response relationship between magnesium depletion scores and the risk of both RA and OA. Each one-point increase in the magnesium depletion score was associated with a 21 percent higher odds of RA and a 12 percent higher odds of OA (Li et al., 2024). That does not prove causation, but it adds to a pattern showing that people with lower magnesium status are more likely to have arthritis.

There is also an overlap worth mentioning: people with magnesium deficiency symptoms like muscle cramps, poor sleep, and fatigue share common complaints with arthritis patients. Even if magnesium is not directly treating the arthritis, correcting a deficiency can improve quality of life in ways that matter.

Rheumatoid arthritis is an autoimmune condition where the immune system attacks the lining of the joints, causing chronic inflammation. This makes RA particularly relevant to magnesium research because of magnesium's documented effects on inflammatory markers.

A 2022 meta-analysis of 17 randomised controlled trials found that magnesium supplementation significantly reduced serum CRP levels and increased nitric oxide (NO) production (Veronese et al., 2022). CRP is one of the key markers clinicians use to track RA disease activity, so a reduction here is clinically meaningful.

An earlier meta-analysis by Simental-Mendia et al. (2017) found something even more specific: magnesium supplementation reduced CRP most significantly in people who already had elevated inflammation (baseline CRP above 3 mg/L). In people with normal CRP, the effect was not significant. This suggests magnesium's anti-inflammatory benefit is most pronounced in people who need it most, which includes many RA patients.

RA patients also tend to have lower serum magnesium levels compared to healthy controls (Vera et al., 2024), and a systematic review confirmed that RA patients frequently show inadequate intake of magnesium alongside calcium, zinc, and vitamin B6 (Elma et al., 2020).

Osteoarthritis is different from RA. It is a degenerative condition driven by cartilage breakdown and mechanical stress rather than autoimmune attack. The research on magnesium and OA is actually more direct.

A population-based study from the Johnston County Osteoarthritis Project found that higher dietary magnesium intake was associated with significantly lower odds of radiographic knee OA. People in the second quintile of magnesium intake had roughly half the odds of knee OA compared to those in the lowest intake group (Qin et al., 2012). Interestingly, additional magnesium beyond that threshold did not provide further benefit, suggesting there is a floor you need to get above rather than a linear dose-response.

An 8-year prospective study using data from the Osteoarthritis Initiative found that higher magnesium intake from both food and supplements was associated with reduced risk of frailty and recurrent falls in OA patients. Each 1 mg per 1000 kcal increase in magnesium intake was linked to a 0.5 percent reduced frailty risk (Zheng et al., 2023). Falls and frailty are major concerns for people with OA, so this has real practical significance even if it is not measuring joint pain directly.

On the other hand, a Finnish cohort study of nearly 5,000 participants found that low dietary magnesium did not predict incident knee OA over a 10-year follow-up (Konstari et al., 2019). That said, the study did confirm that magnesium intake was inversely associated with serum CRP, supporting the anti-inflammatory mechanism even if the primary OA outcome missed significance.

At the preclinical level, a 2019 animal study found that intra-articular magnesium chloride injections significantly reduced cartilage calcification severity in a mouse model of OA (Yue et al., 2019). This is laboratory evidence, not a human supplement trial, but it offers a plausible biological mechanism for how magnesium might protect joints.

The honest answer is that magnesium is not a standalone treatment for arthritis, and no study has shown it can reverse joint damage or replace conventional therapy. But the evidence does point to several ways it can help.

For RA, magnesium supplementation reduces CRP and other inflammatory markers, especially in people who already have elevated inflammation. Since RA patients are frequently low in magnesium, correcting that deficiency supports the same inflammatory pathways that drive disease activity.

For OA, higher magnesium intake is associated with lower odds of knee OA, reduced frailty and falls risk, and better overall musculoskeletal outcomes in observational data. Animal studies suggest magnesium protects cartilage from calcification, though this has not been confirmed in human supplement trials yet.

For both types, the strongest case for magnesium is as a supportive nutrient rather than a primary treatment. If you are deficient (and most people are not getting enough), supplementing can address inflammation, support bone and cartilage health, and improve related symptoms like sleep and muscle tension. You can read more about the full range of magnesium benefits here.

Getting your magnesium intake right matters more than most people realise. The standard RDA sits around 310 to 420 mg per day, but therapeutic dosing based on body weight tends to be more effective for people dealing with chronic inflammation or musculoskeletal conditions.

A target of 7 to 10 mg per kilogram of body weight per day is a good reference point. For a 70 kg person, that is 490 to 700 mg daily. The lower end suits someone who is generally healthy with no active symptoms, while the higher end is more appropriate for people with ongoing joint pain, inflammation, or increased physical demands. You can find a detailed breakdown on the magnesium dosage page.

Combining dietary sources with supplementation is the most practical approach. Magnesium-rich foods like dark leafy greens, pumpkin seeds, and almonds contribute a solid base, but most people fall short of therapeutic levels through food alone. A high-quality magnesium supplement fills that gap.

Be aware of potential magnesium side effects at higher doses, mainly loose stools, which is usually a sign to split your dose or switch to a better-tolerated form like magnesium glycinate.

Not all magnesium forms are equal, and the best magnesium supplement for arthritis depends on what you are trying to address. Here is a quick reference:

A supplement that combines multiple bioavailable forms (like glycinate, citrate, and malate together) covers more bases than relying on a single form. This is the approach used in Biosphere Nutrition's Magnesium Powder, which delivers a therapeutic 400 mg dose across three forms in each serve.

Magnesium is not a cure for arthritis. But calling it irrelevant would be ignoring a significant amount of published research. The clinical picture looks like this:

Magnesium supplementation consistently reduces CRP and other inflammatory markers central to RA disease activity and OA progression. Population data links higher magnesium intake to lower arthritis prevalence, reduced frailty, and better musculoskeletal outcomes. And at the cellular level, magnesium appears to protect cartilage from the calcification that drives OA forward.

What is missing is the definitive randomised controlled trial testing magnesium supplementation as a direct arthritis intervention. Until that exists, the strongest recommendation is simple: make sure you are not deficient. Given that most adults in New Zealand do not meet even the basic RDA for magnesium, that alone is a meaningful step for anyone managing arthritis.